Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults

Journal of Infectious Diseases

Volumn 208, Issue 9, 2013, Pages 1514-1519

  Travassos, Mark A ^a   Niangaly, Amadou ^b   Bailey, Jason A ^a   Ouattara, Amed ^a   Coulibaly, Drissa ^b   Laurens, Matthew B ^a   Pablo, Jozelyn ^c   Jasinskas, Algis ^c   Nakajima Sasaki, Rie ^c   Berry, Andrea A ^a   Takala Harrison, Shannon ^a   Kouriba, Bourema ^b   Rowe, J Alexandra ^d   Lyke, Kirsten E ^a   Doumbo, Ogobara K ^b   Thera, Mahamadou A ^b   Felgner, Philip L ^c   Plowe, Christopher V ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b Sociétés   (Mali)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

immunity; malaria; microarray; PfEMP1; seroreactivity; var genes

Indexed keywords

ERYTHROCYTE MEMBRANE PROTEIN 1; PROTOZOAL PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PEPTIDE FRAGMENT; PROTOZOON ANTIBODY;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; EXTRACELLULAR PROTEIN FRAGMENT; HUMAN; IMMUNOREACTIVITY; INFANT; INNATE IMMUNITY; INTRACELLULAR PROTEIN FRAGMENT; MALARIA FALCIPARUM; MALI; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MICROARRAY; SEASONAL VARIATION; SEROLOGY; SEROPREVALENCE; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; PROTEIN TERTIARY STRUCTURE;

ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MALARIA, FALCIPARUM; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; PROTEIN ARRAY ANALYSIS; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS;

EID: 84885405071     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit339     Document Type: Article

References (15)

1. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg 1989; 83:293-303
2. Rowe JA, Claessens A, Corrigan RA, Arman M. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: Molecular mechanisms and therapeutic implications. Expert Rev Mol Med 2009; 11:e16
3. Kraemer SM, Smith JD. A family affair: Var genes, PfEMP1 binding, and malaria disease. Curr Opin Microbiol 2006; 9:374-80
4. Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002; 419:498-511
5. Kyriacou HM, Stone GN, Challis RJ, et al. Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol Biochem Parasitol 2006; 150:211-8
6. Warimwe GM, Keane TM, Fegan G, et al. Plasmodium falciparum var gene expression is modified by host immunity. Proc Natl Acad Sci U S A 2009; 106:21801-6
7. Rask TS, Hansen DA, Theander TG, Gorm PA, Lavstsen T. Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes -divide and conquer. PLoS Comput Biol 2010; 6:e1000933: 1-23
8. Crompton PD, Kayala MA, Traore B, et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 2010; 107:6958-63
9. Barry AE, Trieu A, Fowkes FJ, et al. The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol Cell Proteomics 2011; 10:M111
10. Davies DH, Liang X, Hernandez JE, et al. Profiling the humoral immune response to infection by using proteome microarrays: Highthroughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 2005; 102:547-52
11. Doolan DL, Mu Y, Unal B, et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008; 8:4680-94
12. Thera MA, Doumbo OK, Coulibaly D, et al. Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: Results of a phase 1 randomized controlled trial. PLoS One 2008; 3:e1465
13. Thera MA, Doumbo OK, Coulibaly D, et al. Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: Results of a phase 1 randomized controlled trial. PLoS One 2010; 5:e9041
14. Ghumra A, Khunrae P, Ataide R, et al. Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosisinducing antibodies to Plasmodium falciparum. PLoS One 2011; 6: E16414
15. Ghumra A, Semblat JP, Ataide R, et al. Induction of strain-Transcending antibodies against group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog 2012; 8:e1002665